NCT04743518 Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis Status RECRUITING Phase PHASE4
NCT04738942 A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04722757 Comparison of Functional Outcomes Between Transanal and Laparoscopic vs Open Ileal Pouch-Anal Anastomosis Status UNKNOWN Phase NA
NCT04709445 Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses Status UNKNOWN Phase NA
NCT04706793 Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) Status COMPLETED Phase PHASE3
NCT04695964 Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis Status UNKNOWN Phase NA
NCT04695184 Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis Status UNKNOWN Phase NA
NCT04691232 Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT04687150 Fecal Microbiota Transplantation and Newly Diagnosed Ulcerative Colitis (UC) Status UNKNOWN Phase NA
NCT04659148 Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal Cancer Status UNKNOWN Phase N/A
NCT04650867 Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography Status COMPLETED Phase N/A
NCT04626947 Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). Status TERMINATED Phase PHASE4
NCT04624230 Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04607837 Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis Status COMPLETED Phase PHASE2